Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$133K Sell
1,463
-870
-37% -$79.4K 0.01% 163
2026
Q1
$240K Buy
2,333
+264
+13% +$29.8K 0.02% 85
2025
Q4
$259K Sell
2,069
-9,871
-83% -$1.26M 0.03% 75
2025
Q3
$1.6M Hold
11,940
0.29% 46
2025
Q2
$1.62M Buy
11,940
+1,000
+9% +$132K 0.32% 42
2025
Q1
$1.45M Sell
10,940
-848
-7% -$108K 0.31% 44
2024
Q4
$1.33M Buy
11,788
+325
+3% +$37.6K 0.28% 47
2024
Q3
$1.31M Sell
11,463
-400
-3% -$43.9K 0.28% 49
2024
Q2
$1.23M Sell
11,863
-3,813
-24% -$404K 0.29% 48
2024
Q1
$1.78M Sell
15,676
-607
-4% -$69.6K 0.46% 31
2023
Q4
$1.79M Buy
+16,283
New +$1.63M 0.5% 30

Other funds holding ABT

Arlington Trust's ABT Position: Q2 2026 in Review

Arlington Trust reduced its Abbott (ABT) stake by 37% in Q2 2026, selling an estimated $79.4K and leaving 1,463 shares worth $133K. The position accounts for 0.01% of the portfolio, ranked #163.

Arlington Trust first reported a position in ABT in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.79M in Q4 2023. 530 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Arlington Trust held 1,463 shares of Abbott worth $133K as of Q2 2026.
  • Arlington Trust sold 870 Abbott shares in Q2 2026, an estimated $79.4K.
  • Abbott made up 0.01% of Arlington Trust's portfolio in Q2 2026, its #163 holding.
  • Arlington Trust first reported a position in Abbott in Q4 2023 and has held it in 11 quarters since.
  • Arlington Trust's Abbott position peaked at $1.79M in Q4 2023.
  • 530 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.